Article
General maternal medication use, folic acid, the MDR1 C3435T polymorphism, and the risk of a child with a congenital heart defect.
American journal of obstetrics and gynecology - 1 Mar 2011
Obermann-Borst Sylvia A, Isaacs Aaron, Younes Zobia, van Schaik Ron H N, van der Heiden Ilse P, van Duyn Cornelia M, Steegers Eric A P, Steegers-Theunissen Régine P M
Abstract excerpt
OBJECTIVE: We sought to investigate maternal and child functional MDR1 C3435T polymorphism, periconception medication, folic acid use, and the risk of a congenital heart defect (CHD) in the offspring. STUDY DESIGN: MDR1 3435C>T genotyping was performed in 283 case triads (mother, father, child) and 308 control triads. Information on periconception medication and folic acid use was obtained through questionnaires....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
